Overview
Wu Dai practices in Hefei, China. Dai is highly rated in 3 conditions, according to our data. Their top areas of expertise are Autonomic Neuropathy, Metabolic Syndrome, Diabetic Neuropathy, and Type 2 Diabetes (T2D).
Their clinical research consists of co-authoring 23 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Autonomic Neuropathy
- Diabetic NeuropathyDai isAdvanced. Learn about Diabetic Neuropathy.
- Metabolic SyndromeDai isAdvanced. Learn about Metabolic Syndrome.
- Experienced
- Castleman DiseaseDai isExperienced. Learn about Castleman Disease.
- Diabetic NephropathyDai isExperienced. Learn about Diabetic Nephropathy.
- Low Blood SugarDai isExperienced. Learn about Low Blood Sugar.
- Lymphofollicular Hyperplasia
- Maturity Onset Diabetes of the Young
- Muscle AtrophyDai isExperienced. Learn about Muscle Atrophy.